tm logo

Monitor this mark

View On USPTO

TYZAVAN
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 09 Jul 2024

Last Applicant/ Owned by

Xellia Pharmaceuticals ApS

Dalslandsgade 11

Copenhagen S

DK

2300

Serial Number

98113173 filed on 02th Aug 2023

Registration Number

N/A

Correspondent Address

Deborah L. Corpus

Deborah L. Corpus Chrisman Gallo Tochtrop LLC

Independence, OH 44131-4854

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

TYZAVAN

Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals

Classification Information

Class [005]
Pharmaceutical Products

Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98113173

Mark Type

No Service/Collective Mark

Attorney Docket Number

No WSTW1-71143

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
19th Nov 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19th Nov 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19th Nov 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Jul 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th May 2024PUBLISHED FOR OPPOSITION
24th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
04th Apr 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04th Apr 2024EXAMINERS AMENDMENT E-MAILED